5
The Scheme 2 represents a plausible mechanism for the
three component reaction leading to the compound 10. The
nucleophilic attack of primary amine on carbonyl group of
isatoic anhydride followed by ring opening and subsequent
decarboxylation will yield to compound 14. Deprotonation
of aromatic amine 15 in the presence of base followed by
nucleophilic attack to the nitrile group, 13 will yield imine
16; subsequent cyclization followed by elimination of N-
phenyl tosyl group will yield intermediate 17. Cyclization of
compound 18 will yield compound 19. The intermediate 19
will undergo tautomerization leading to the formation of 10.
Scheme 2: The proposed reaction mechanism for the formation of 10.
Bereznak, J. F.; Chang, Z. Y.; Sternberg, C. G.; PCT Int. Appl.
WO 9702262 (1997) [Chem. Abstr. 1998, 129, 132536w]; (c)
Bartroli, J.; Turmo, E.; Alguero, M.; Boncompte, E.; Vericat, M.
L.; Conte, L.; Ramis, J.; Merlos, M.; Garcia-Rafanell, J.; Forn, J.
J. Med. Chem. 1998, 41, 1869-1882.
Conclusion:
In conclusion, we have developed a novel multi-component
reaction strategy for the synthesis of 2-amino 3- substituted
quinazolinone in good yields from isatoic anhydride, amine
and electrophilic cyanating agent, N-cyano-4-methyl-N-
phenylbenzenesulfonamide in a one pot process. The
synthesis of 2-amino 3- substituted quinazolinone proceeded
4.
5.
Pandeya, S. N.; Sriram, D.; Nath, G.; De Clercq, E. Pharm.Acta
Helv. 1999, 74, 11–17; (b) Shiba, S. A.; El-Khamry, A. A.;
Shaban, M. E.; Atia, K. S. Pharmazie 1997, 52, 189–194.
(a) Harayama, T.; Morikami, Y.; Shigeta, Y.; Abe, H.; Takeuchi,
Y. Synlett, 2003, 847-848; (b) Ma, Z.; Hano, Y.; Nomura, T.;
Chen, Y. Biorg. Med. Chem. Lett. 2004, 14, 1193-1196; (c)
Tseng, M. C.; Chu, Y. W.; Tsai, H. P.; Lin, C. M. Hwang, J.; Chu,
Y. H. Org. Lett. 2011, 13, 920-923; (d) Mhaske, S. B.; Argade, N.
P. J. Org. Chem. 2004, 69, 4563-4566; (e) Chavan, S. P.; Sivappa,
R. Tetrahedron, 2004, 60, 9931-9935; (f) Wagh, M. B.; Shankar,
R.; Kumar, U. K. S.; Gill, C. H. Synlett, 2011, 84-88; (g)
Nagarapu, L.; Gaikwad, H. K.; Bantu R. Synlett, 2012, 23, 1775–
1778.
via
a
series of reactions such as ring opening,
dehydration, elimination and
decarboxylation,
heterocycloannulation.
Acknowledgments:
The authors would like to thank Dr. Vilas Dahanukar, Dr.
Rama Mohan, Dr. K. B. Shiva Kumar and the analytical
group of CPS-DRL for spectral data.
6.
(a) Bubenyak, M.; Palfi, M.; Takacs, M.; Beni, S.; Szoko, E.;
Noszál, B.;Kokosi, J. Tetrehedron Lett.2008, 49, 4937-4940. (b)
Bergman, J.; Bergman, S. J. Org. Chem. 1985, 50, 1246.
Friedländer, P.; Roschdestwensky, N. Chem. Ber. 1915, 48, 1841.
(a) Bowman, W. R.;Elsegood, M. R.; Stein, T.; Weaver, G. W.
Org. Biomol. Chem. 2007, 5, 103–113; (b) Mhaske, S. B.;
Argade, N. P. Tetrahedron, 2004, 60, 3417–3420; (c) Kamal, A.;
Ramana, A. V.; Reddy, K. S.; Ramana, K. V.; Babu, A. H.;
Prasad, B. R. Tetrahedron Lett. 2004, 45, 8187–8190.
References:
1.
Skelton, L.; Bavetsias, V.; Jackman, A. WO 0050417
(2000)[Chem. Abstr. 2000, 133, 207917q].
7.
8.
2.
(a) Santagati, N. A.; Bousquet, E.; Spadaro, A.; Ronsisvalle, G.
Farmaco. 1999, 54, 780; (b) Dickinson, R. P.; Bell, A.s.;
Hitchcock, C. A.; Narayana-Swami, S.; Ray, S. J.; Richardson,
K.; Troke, P. F.; Bioorg. Med. Chem. Lett. 1996, 6, 2031; (c)
Nagai, S. I.; Takemoto, S.; Ueda, T.; Mizutani, K.; Uozumi, Y.;
Tokuda, H.; J. Heterocycl. Chem. 2001, 38, 1097.
9.
Ziaee, V.; Jalalizadeh, H.; Iranshahi, M.; Shafiee, A. Iran. J.
Chem. Chem. Eng. 2004, 23, 33. (b) Kamal, A.; Ramana, V. K.;
Rao, M. V. J. Org. Chem. 2001, 66, 997.
3.
(a) Bereznak, J. F.; Chang, Z. Y.; Selby, T. P.; Sternberg, C. G.
US 5945423 (1999). [Chem. Abstr. 1999, 131, 170360h]; (b)